Erie Indemnity Director Receives Deferred Stock Grant
ERIE INDEMNITY CO
Subscribe to track ERIE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Erie Indemnity Director Receives Deferred Stock Grant
Company: ERIE INDEMNITY CO (ERIE) Form: 4 | Filed: 2025-11-03 Significance: Low
Insider: Hudson Brian Arden Sr. Title: Director | Relationship: Director
Transaction: • Type: Grant (Deferred Comp) • Shares: 39.474 • Price: $292.64 • Value: $11,553 • Owned After: 3,249 (Share Credits)
Key Insight: A routine acquisition of deferred stock units by a director as part of their compensation plan, representing a negligible fraction of the company's market cap.
Market Context: The transaction is immaterial against Erie's $15.30 billion market capitalization and has no significant market impact.
Comprehensive Analysis
SEC Filing Analysis: ERIE INDEMNITY CO (ERIE)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a small, routine grant of deferred stock units as part of their compensation, with no meaningful market impact.
- Market Impact: Neutral. The transaction is too small to influence market sentiment or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | ERIE INDEMNITY CO |
| Ticker Symbol | ERIE |
| CIK | 0000922621 |
| Industry | INSURANCE AGENTS BROKERS & SERVICES |
Insider Information
| Field | Value |
|---|---|
| Name | Hudson Brian Arden Sr. |
| CIK | 0001705005 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-31 |
| Transaction Code | J (Other acquisition) |
| Security Type | Directors' Deferred Compensation Share Credits |
| Shares Involved | 39.474 |
| Price Per Share | $292.64 |
| Total Value | $11,553.06 |
| Shares Owned After | 3248.955 (Derivative Securities) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $11,553.06 |
| % of Market Cap | <0.0001% |
| Shares Transacted | 39.474 |
| % of Shares Outstanding | <0.0001% |
| Post-Transaction Ownership | 3,248.955 derivative shares (0.007% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value of approximately $11.5k is negligible for a company with a market capitalization of $15.30 billion.
- Ownership Concentration: The director's total derivative holdings remain a very small fraction of the company's total shares outstanding, indicating low ownership concentration from this individual.
- Dilution Impact: The grant of ~39 share equivalents has a virtually zero dilutive effect on the 46.2 million shares outstanding.
- Transaction Significance: This is a routine, non-discretionary transaction related to director compensation and does not provide any new insight into the insider's view of the company's future prospects.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is a standard compensation grant, not an open-market purchase. Its size is immaterial relative to the company's market cap and daily trading volume.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is too small to affect trading volume.
- Sentiment Indicator: Neutral. This type of filing is common and does not typically influence investor sentiment.
Additional Context
Transaction Notes
- Special Circumstances: The transaction involves the acquisition of 'Share Credits' under the Outside Directors' Deferred Compensation Plan. These credits represent the right to receive an equivalent number of Class A common stock shares upon the termination of the director's service. They are not immediately tradable.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
